Коррекция клинических проявлений эндометриоза и нарушений менструального цикла

Authors

  • Г. Ф. Рощина Национальная медицинская академия последипломного образования им. П.Л. Шупика, Ukraine

DOI:

https://doi.org/10.18370/2309-4117.2012.4.58-65

Abstract

Эндометриоз – единственный в своем роде дисгормональный процесс, обладающий способностью к инфильтративному росту и метастазированию. Это заболевание характеризуется разрастанием эндометриоидной ткани за пределами эндометрия, которая по морфологическим признакам подобна слизистой оболочке матки [1-3, 7].

Author Biography

Г. Ф. Рощина, Национальная медицинская академия последипломного образования им. П.Л. Шупика

PhD, Associate Professor, Department of Obstetrics and Gynecology number 1

References

  1. Адамян Л.А., Кулаков В.И. Эндометриозы. – М.: Медицина, 1998. – 316 с.
  2. Андреева Е.Н. Распространенные формы генитального эндометриоза. Медико-генетические аспекты, диагностика, клиника, лечение и мониторинг больных.: Автореф. дис. канд. мед. наук. – М. – 1997. – 50 с.
  3. Баскаков В.П., Цвелев Ю.В., Кира Е.Ф. Диагностика и лечение эндометриоза на современном этапе. – СПб.: НЛ, 1998. – 452 с.
  4. Всемирный конгресс по менопаузе. – Рим, 2011. – Тезисы. – С.109.
  5. Кулаков В.И., Адамян Л.А., Аскольская С.И. Гистерэк-томия и здоровье женщины. – М.: Медицина, 1999. – 312 с.
  6. Справочник по акушерству, гинекологии и перинатологии / Под ред. акад. РАМН Г.М. Савельевой. – М.: МИА, 2006. – С. 518-526.
  7. Хмельницкий О.К. Патоморфологическая диагностика гинекологических заболеваний. – СПб.: СОТИС, 1994. – 480 с.
  8. Bazin B., Thevenot R., Bursaux C. et al. Effect of nomegestrol acetate, a new 19-nor_progesterone derivative, on pituitary ovarian function in women. Br J Obstet Gynaecol 1987 Dec; 94 (12): 1199-1204.
  9. Bullock L.P., Bardin C.W. Androgenic, synandrogenic, and antiandrogenic actions of progestins. Ann N Y Acad Sci 1977 Mar 11; 286: 321-330.
  10. Cohen A., Engelmann P., Erny R. et al. Lutenyl and menstrual disorders: a hospital study. Rev Fr Gynecol Obstet 1988 Nov; 83 (11): 741-743.
  11. Cohen A. Multicenter study of the clinical use of nomegestrol acetate in outpatients. Contracept Fertil Sex (Paris) 1994; 21: 417-427.
  12. Conard J., Basdevant A., Thomas J.L. et al.Cardiovascular risk factors and combined estrogen_progestin replacement therapy: a placebo_controlled study with nomegestrol acetate and estradiol. Fertil Steril 1995 Nov; 64 (5): 957-962.
  13. Couzinet B., Young J., Brailly S. et al. The antigonadotropic activity of progestins (19-nortestosterone and 19-norprogesterone derivatives) is not mediated through the androgen receptor. J Clin Endocrinol Metab 1996 Dec; 81 (12): 4218-4223.
  14. Couzinet B., Young J., Kujas M. et al. The antigonadotropic activity of a 19-norprogesterone derivative is exerted both at the hypothalamic and pituitary levels in women. J Clin Endocrinol Metab 1999 Nov; 84 (11): 4191-4196.
  15. De Leo V., la Marca A., Morgante G. et al. Comparison of two HRT regimens with bimonthly and monthly progestin administration in postmenopause.Maturitas 1999 Jan 4; 31 (2): 171-177.
  16. Donnez J., Nisolle M. Laparoscopic menegment of large ovarian endometrial cysts // J. Gynecol. Surg. – 1991. – Vol. 7. – P. 163-167.
  17. Donnez J., Nisolle M., Casanas-Roux F. et al. Endometriosis rational for surgeri. The current status of endometriosis. – 1993. – P. 385-395.
  18. Duc I., Botella J., Bonnet P., et al. Antiandrogenic properties of nomegestrol acetate. Arzneimittelforschung 1995 Jan; 45 (1): 70-74.
  19. Dusterberg B., Humpel M., Speck U. Terminal half_lives in plasma and bioavailability of norethisterone, levonorgestrel, cyproterone acetate and gestodene in rats, beagles and rhesus monkeys. Contraception 1981 Dec; 24 (6): 673-683.
  20. Ezan E., Benech H., Bucourt R. et al. Enzyme immunoassay for nomegestrol acetate in human plasma. J Steroid Biochem Mol Biol 1993 Oct; 46 (4): 507-514.
  21. Fraser D.I., Padwick M.L., Whitehead M.I. et al. The effects of the addition of nomegestrol acetate to postmenopausal oestrogen therapy. Maturitas1989 Mar; 11 (1): 21-34.
  22. Gleicher N., Dmowski W.P., Siegel I. Lymfocyte subsets in endometriosis. Obstet Gynecol 1984; 63: 463.
  23. Kennedy S. The genetics of endometriosis//J Reprod Med 1998: 43; 263-268.
  24. Kuhl H. Comparative pharmacology of newer progestogens. Drugs 1996 Feb; 51 (2): 188-15.
  25. Kumar N., Koide S.S., Tsong Y. et al. Nestorone: a progestin with a unique pharmacological profile. Steroids 2000 Oct_Nov; 65 (10-11): 629-636.
  26. Paris J., Thevenot R., Bonnet P. et al. The pharmacological profile of TX 066 (17 alpha-acetoxy-6-methyl-19-nor-4,6-pregnadiene-3,20-dione), a new oral progestative Arzneimittelforschung 1983; 33 (5): 710-715.
  27. Pasqualini J.R. Progestins and breast cancer. Gynecol Endocrinol 2007 Oct; 23 Suppl. 1: 32-41.
  28. Persiani P., Radici E., Lombardi P.A. et al. Use of nomegestrol acetate in the treatment of menstruation disorders: our experience in 56 cases. Minerva Ginecol 1997 Apr; 49 (4): 181-185.
  29. Redwin D.B. Laparoscopic approach to the diagnosis of endometriosis. Матер. межд. конгресса. – М. – 1996. – С. 128-136.
  30. Sampson J.A. Perforating hemorrhagic (chocolate) cysts of the ovary. Arch. Surg. – 1991. – P. 245-323.
  31. Schindler A.E., Campagnoli C., Druckmann R. et al.Classification and pharmacology of progestins. Maturitas 2003 Dec 10; 46 Suppl. 1: S7-16.
  32. Shaw R.W. Atlas of endometriosis. The Parthenon Publishing Group. – 1993. – P. 31-32.
  33. Sitruk-Ware R. New progestogens: a review of their effects in perimenopausal and postmenopausal women. Drugs Aging 2004; 21 (13): 865-883.
  34. Sitruk-Ware R. Pharmacological profile of progestins. Maturitas 2004 Apr 15; 47 (4): 277-283.
  35. Sitruk-Ware R. New progestagens for contraceptive use. Hum Reprod Update 2006 Mar_Apr; 12 (2): 169-178.
  36. Stefano Lello Drugs 2010: 70 (5): 541-559

Downloads

Published

2012-05-13

How to Cite

Рощина, Г. Ф. (2012). Коррекция клинических проявлений эндометриоза и нарушений менструального цикла. REPRODUCTIVE ENDOCRINOLOGY, (4), 58–65. https://doi.org/10.18370/2309-4117.2012.4.58-65

Issue

No. 4 (2012)

Section

Gynecology

License

Copyright (c) 2014 Г. Ф. Рощина

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.